(Q54576126)

1 June 2018

title

Silencing the receptor EphA2 suppresses the growth and haptotaxis of malignant mesothelioma cells. (English)

1 reference

1 June 2018

author name string

Najmunnisa Nasreen

series ordinal

1

1 reference

1 June 2018

Kamal A Mohammed

series ordinal

2

1 reference

1 June 2018

Veena B Antony

series ordinal

3

1 reference

1 June 2018

language of work or name

English

0 references

publication date

1 November 2006

1 reference

1 June 2018

published in

Cancer

1 reference

1 June 2018

volume

107

1 reference

1 June 2018

issue

10

1 reference

1 June 2018

page(s)

2425-2435

1 reference

1 June 2018

Malignant pleural mesothelioma and epidermal growth factor receptor (EGF-R). Relationship of EGF-R with histology and survival using fixed paraffin embedded tissue and the F4, monoclonal antibody

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

21 January 2018

Mechanisms of apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

7 January 2021

Continuing increase in mesothelioma mortality in Britain.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

7 January 2021

Distinct and overlapping expression patterns of ligands for Eph-related receptor tyrosine kinases during mouse embryogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

7 January 2021

ECK, a human EPH-related gene, maps to 1p36.1, a common region of alteration in human cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

7 January 2021

Overexpression of protein tyrosine kinases in human esophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

7 January 2021

Overexpression of the EphA2 tyrosine kinase in prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

7 January 2021

The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

7 January 2021

EphA2 expression is associated with aggressive features in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

7 January 2021

Immunoreactivity for cadherins, HGF/SF, met, and erbB-2 in pleural malignant mesotheliomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

7 January 2021

Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

7 January 2021

EPHA2/EFNA1 expression in human gastric cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

7 January 2021

The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

7 January 2021

Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

7 January 2021

Pleural mesothelial cell (PMC) defense mechanisms against malignancy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

7 January 2021

Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

7 January 2021

Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

7 January 2021

Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

7 January 2021

The ephrins and Eph receptors in angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

7 January 2021

Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

7 January 2021

An ephrin mimetic peptide that selectively targets the EphA2 receptor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

7 January 2021

Cellular and molecular parameters of mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

7 January 2021

SV40 enhances the risk of malignant mesothelioma among people exposed to asbestos: a molecular epidemiologic case-control study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22254

7 January 2021

Identifiers

DOI

10.1002/CNCR.22254

1 reference

1 June 2018

1 reference

1 June 2018